当前位置:首页 - 行情中心 - 信邦制药(002390) - 财务分析 - 现金流量表

信邦制药

(002390)

  

流通市值:63.62亿  总市值:64.15亿
流通股本:19.28亿   总股本:19.44亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,196,706,849.045,867,264,378.244,392,910,428.842,916,946,301.83
  收到其他与经营活动有关的现金67,159,652.95122,520,087.7996,340,560.9491,226,791.48
  经营活动现金流入小计1,263,866,501.995,989,784,466.034,489,250,989.783,008,173,093.31
  购买商品、接受劳务支付的现金898,223,279.373,984,561,846.823,053,053,427.032,134,493,536.85
  支付给职工以及为职工支付的现金200,210,605.37698,424,171.01544,680,196.39377,438,379.22
  支付的各项税费54,360,511.18243,520,403.14161,804,358.2895,985,631.81
  支付其他与经营活动有关的现金65,560,754.29330,747,422.55268,130,705.72172,829,897.63
  经营活动现金流出小计1,218,355,150.215,257,253,843.524,027,668,687.422,780,747,445.51
  经营活动产生的现金流量净额45,511,351.78732,530,622.51461,582,302.36227,425,647.8
二、投资活动产生的现金流量:
  收回投资收到的现金300,000,000220,743,323.4410,000,00010,000,000
  取得投资收益收到的现金1,034,803.2719,832,583.06341,843.03304,964.14
  处置固定资产、无形资产和其他长期资产收回的现金净额382,6506,330,361.31788,991.7741,194.9
  投资活动现金流入小计301,417,453.27246,906,267.8111,130,834.7311,046,159.04
  购建固定资产、无形资产和其他长期资产支付的现金2,042,391.0285,420,518.8766,335,825.5955,902,231.35
  投资支付的现金300,000,000200,000,000--
  投资活动现金流出小计302,042,391.02285,420,518.8766,335,825.5955,902,231.35
  投资活动产生的现金流量净额-624,937.75-38,514,251.06-55,204,990.86-44,856,072.31
三、筹资活动产生的现金流量:
  取得借款收到的现金118,000,000440,000,000382,000,000358,000,000
  收到其他与筹资活动有关的现金74,358,466.2982,795,072.5682,795,072.5682,795,072.56
  筹资活动现金流入小计192,358,466.29522,795,072.56464,795,072.56440,795,072.56
  偿还债务支付的现金118,000,000766,200,000613,200,000409,300,000
  分配股利、利润或偿付利息支付的现金3,797,792.21260,501,338.54219,858,190.48141,295,651.96
  其中:子公司支付给少数股东的股利、利润-129,678,950102,534,95073,869,950
  支付其他与筹资活动有关的现金58,955,535.3183,306,876.2449,660,193.0148,511,212.34
  筹资活动现金流出小计180,753,327.521,110,008,214.78882,718,383.49599,106,864.3
  筹资活动产生的现金流量净额11,605,138.77-587,213,142.22-417,923,310.93-158,311,791.74
四、汇率变动对现金及现金等价物的影响-1,328.773,141.57-1,859.813,735.54
五、现金及现金等价物净增加额56,490,224.03106,806,370.8-11,547,859.2424,261,519.29
  加:期初现金及现金等价物余额1,039,526,611.64932,720,240.84932,720,240.84932,720,240.84
  期末现金及现金等价物余额1,096,016,835.671,039,526,611.64921,172,381.6956,981,760.13
补充资料:
  净利润-191,795,599.53-142,445,335.96
  资产减值准备-112,443,211.54-6,287,040.22
  固定资产和投资性房地产折旧-182,450,207.32-92,264,340.2
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-182,450,207.32-92,264,340.2
  无形资产摊销-14,814,843.02-7,410,658.84
  长期待摊费用摊销-14,317,244.69-6,805,008.7
  处置固定资产、无形资产和其他长期资产的损失-3,481,951.16--95,696.33
  固定资产报废损失-2,525,190.36-832,085.64
  财务费用-22,451,423.54-12,446,340.67
  投资损失--19,740,275.61--304,964.14
  递延所得税--28,811,956.39--97,792.34
  其中:递延所得税资产减少--28,400,536.61-14,794.07
    递延所得税负债增加--411,419.78--112,586.41
  存货的减少-147,627,246.85-102,722,036.05
  经营性应收项目的减少-288,636,052.61-57,252,761.75
  经营性应付项目的增加--204,411,362.91--203,361,597.48
  不涉及现金收支的投资和筹资活动金额其他项目-744,056.24--
  现金的期末余额-1,039,526,611.64-956,981,760.13
  减:现金的期初余额-932,720,240.84-932,720,240.84
  现金及现金等价物的净增加额-106,806,370.8-24,261,519.29
公告日期2026-04-292026-04-212025-10-292025-08-30
审计意见(境内)标准无保留意见
TOP↑